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Abstract
Background: The global spread of HIV-1 has been accompanied by the emergence of genetically distinct viral strains. Over
the past two decades subtype C viruses, which predominate in Southern and Eastern Africa, have spread rapidly throughout
parts of South America. Phylogenetic studies indicate that subtype C viruses were introduced to South America through a
single founder event that occurred in Southern Brazil. However, the external route via which subtype C viruses spread to the
South American continent has remained unclear.
Methodology/Principal Findings: We used automated genotyping to screen 8,309 HIV-1 subtype C pol gene sequences
sampled within the UK for isolates genetically linked to the subtype C epidemic in South America. Maximum likelihood and
Bayesian approaches were used to explore the phylogenetic relationships between 54 sequences identified in this screen,
and a set of globally sampled subtype C reference sequences. Phylogenetic trees disclosed a robustly supported
relationship between sequences from Brazil, the UK and East Africa. A monophyletic cluster comprised exclusively of
sequences from the UK and Brazil was identified and dated to approximately the early 1980s using a Bayesian coalescent-
based method. A sub-cluster of 27 sequences isolated from homosexual men of UK origin was also identified and dated to
the early 1990s.
Conclusions: Phylogenetic, demographic and temporal data support the conclusion that the UK was a crucial staging post
in the spread of subtype C from East Africa to South America. This unexpected finding demonstrates the role of diffuse
international networks in the global spread of HIV-1 infection, and the utility of globally sampled viral sequence data in
revealing these networks. Additionally, we show that subtype C viruses are spreading within the UK amongst men who have
sex with men.
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Introduction
Founder effects, genetic drift and recombination associated with
the global spread of HIV-1 infection have given rise to genetically
distinct viral strains referred to as ‘subtypes’ and ‘circulating
recombinant forms’ [1]. HIV-1 genetic diversity may impact on
disease progression and response to antiretroviral therapy, and has
implications for vaccine development [2]. It is therefore important
to monitor changes in the genetic and geographic complexity of
the HIV-1 epidemic, and to identify the processes that drive these
changes.
Of the various HIV-1 strains that have been described, the most
prevalent worldwide is subtype C [3]. First described in East and
Southern Africa [4], infections with viruses belonging to (or
partially derived from) subtype C are now prevalent in regions
throughout the world, including India, China, and South America
[3,5,6]. In many of the regions where it has been introduced,
subtype C has overtaken other HIV-1 strains introduced at earlier
times [6–9]. Notably, studies suggest that subtype C may acquire
multi-drug resistance more rapidly than other HIV-1 subtypes
[10,11].
The rapid spread of subtype C in regions of South America -
including Brazil, Argentina and Uruguay - has drawn particular
attention [12–16]. Recent studies indicate that the South
American subtype C epidemic likely derives from a single founder
virus that entered the continent via Southern Brazil, and was
derived from viral strains prevalent in East Africa [12,13].
However, the external route via which this virus spread from
East Africa to South America has remained mysterious.
In the United Kingdom (UK), the prevalence of subtype C has
increased steadily since the early 1990s, and it now ranks as the
second most prevalent HIV-1 subtype after subtype B [17]. The
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individuals whose reported exposure risk is heterosexual contact,
and who were likely infected in Southern or Eastern Africa [18].
However, in a previous analyses of HIV-1 genetic diversity [19],
we observed that some subtype C isolates sampled within the UK
exhibit high levels of genetic similarity to isolates obtained in
South America. To explore this finding in greater detail, we
screened 8,309 subtype C sequences sampled within the UK to
identify isolates genetically linked to the South American
epidemic. We then examined the genetic relationships of these
isolates to subtype C isolates sampled worldwide.
Methods
Study Group and Reference Sequences
8,309 subtype C pol gene sequences sampled within the UK
were obtained from the UK HIV Drug Resistance Database
(www.hivrdb.org.uk). These sequences were generated by popu-
lation sequencing from plasma samples collected between 1996
and 2008, and were anonymously linked to data (obtained under
voluntary agreement of patients) describing the ethnicity, nation-
ality (country of birth) and exposure risk group of infected
individuals. Sequences were at least 1000 nucleotides in length,
spanning the genomic region between 2,253 and 3,251 nucleotides
(HXB2 coordinates). Sequences are available on request from the
UK HIV Drug Resistance Database.
A globally sampled reference sequence set comprising 1,289
previously published subtype C pol gene sequences annotated by
country of sampling was obtained from the Los Alamos HIV
Sequence Database (www.hiv.lanl.gov). The reference set included
sequences from Argentina (n=8), Burundi (n=92), Brazil
(n=122), Botswana (n=144), Ethiopia (n=101), India (n=74),
Kenya (n=3), Tanzania (n=65), Uganda (n=11), South Africa
(n=667) and the UK (n=2). The IDs of reference sequences used
in this study are provided as supplementary information (File S1).
Sequence Analysis
Sequences were classified into phylogenetic groups (i.e.
subtypes, circulating recombinant forms and within-subtype
lineages) using the REGA HIV-1 subtyping tool (version 2.0,
available at: www.bioafrica.net) [20–22]. Sequence alignments
were created using MUSCLE [23] and manually edited.
Maximum likelihood phylogenies were constructed using PhyML
[24] and parameters estimated from the dataset (nucleotide
substitution model=HKY85, transition/transversion ratio=4.0,
gamma shape parameter=0.780). Bayesian phylogenetic analysis
was performed using MrBayes v3.1.2 [25]. Bayesian phylogenies
were inferred using the GTR+I+C nucleotide substitution selected
using Modeltest [26]. For each dataset, two runs (one cold and one
tree heated, tempJ0.20) of four chains each were run for 10
7
generations, with trees sampled every 1000
th generation. The
burn-in of 10% was excluded from the analysis. Convergence of
parameters was assessed by calculating the effective sample size
(ESS) using TRACER v1.4 [27], excluding an initial 10% for each
run. All parameters estimates for each run showed ESS values
more than 300. Shared drug resistance mutations were identified
using the calibrated population resistance (CPR) tool [28].
Estimation of Evolutionary Rates and Dates
All sequences used for estimation of dates were examined for
evidence of inter- and intra-subtype recombination. Sequences
that were not classified as pure (non-recombinant) subtype C by
REGA (inter-subtype recombination) [21,22] and SCUEL (intra-
subtype recombination) [29] were excluded. Estimates of the
evolutionary rate and the date of the most recent common
ancestor (MRCA) were performed using a Bayesian Markov chain
Monte Carlo (MCMC) approach as implemented in BEAST v1.7.
Analyses were performed with a Bayesian Skyline coalescent tree
prior, under the GTR + I + C model of nucleotide substitution,
and using both a strict and a relaxed molecular clock (uncorrelated
Lognormal model). Two separate MCMC chains were run for 10
8
generations for each dataset, sampled every 10,000
th generation.
BEAST output was analyzed using TRACER v1.4 [27], with
uncertainty in parameter estimates reflected in the 95% highest
probability density (HPD) values after excluding a burn-in of 10%.
Results
An automated genotyping procedure [21,22] was used to screen
8,309 subtype C pol gene sequences from the UK for isolates
genetically linked to the subtype C epidemic in South America
(data not shown). Screening identified a minority of sequences
(n=54, ,1%) potentially linked to the South American subtype C
epidemic. These 54 sequences were aligned with a set of 1,289
globally sampled reference sequences, plus 84 additional sequences
from the UK. A maximum likelihood (ML) phylogeny constructed
using this alignment confirmed the relationship between the 54
UK sequences and South American isolates, disclosing a well-
supported monophyletic group comprised exclusively of subtype C
pol genes sampled in East Africa, Brazil and the UK (Figure S1,
Figure S2). Notably, sequences from the UK were intermingled
with sequences from Brazil within this clade. Previously, no isolate
obtained outside South America has been reported to group
within the monophyletic lineage defined by South American
subtype C isolates.
To explore these relationships in greater depth, we conducted a
detailed Bayesian Markov chain Monte Carlo (MCMC) phyloge-
netic analysis using all 54 UK sequences identified by screening,
and a representative set of 207 reference sequences from Africa
(n=110), Asia (n=10) and Brazil (n=87). The Bayesian skyline
and relaxed clock models were selected over demographic
(constant and exponential growth) and strict molecular clock
models using Bayes factor analysis [30] (support .20 at log10
Bayes factor scale). The mean mutation rate for the Bayesian
skyline relaxed clock model was estimated as 1.81610
23
nucleotide substitutions per site per year (HPDs 1.27 to
2.37610
23), within the range of rates obtained for approximately
equivalent genomic regions in previous studies (Table S1). All
Bayesian MCMC independent runs converged to almost identical
values for all parameters, and the ESS values for estimates were
more than 300.
As shown in Figure 1, Bayesian trees supported the grouping of
East African, UK and Brazilian isolates into a single monophyletic
cluster. Within this cluster, East African isolates (from Ethiopia
and Burundi) grouped basally, whereas Brazilian and UK isolates
occupied more derived positions. A total of 43 sequences from the
UK grouped together with 86 Brazilian sequences to form a single
monophyletic clade, while a smaller number of UK sequences
(n=11) grouped basally with respect to this ‘UK-Brazil’ clade
(Figure 1). Amongst the eleven UK sequences positioned basal to
the UK-Brazil clade, those positioned nearer the tree root were
obtained from East African immigrants, whereas those occupying
more derived positions were obtained from individuals born
outside Africa.
Within the UK-Brazil clade, sequences from both geographic
regions were generally intermixed. However, 27 UK sequences
formed a single well-supported group displaying short branch
lengths suggestive of a local transmission chain [31]. Exposure risk
South American Subtype C
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these infections; revealing that all were obtained from Caucasians,
the majority of whom (87%, n=13) were men who have sex with
men (MSM). Country of birth was reported for eleven individuals
in this ‘UK-MSM’ cluster, revealing that seven (64%) were born in
the UK. Overall these data stand in contrast to the majority of
subtype C sequences from the UK for which similar data were
available (n=2332), most of which were obtained from individuals
who were African by ethnicity and country of birth (73%), and/or
reported their exposure risk as heterosexual sex (84%).
The grouping of subtype C sequences into ‘East Africa-UK-
Brazil’, ‘UK-Brazil’, and ‘UK-MSM’ clusters was supported by
high posterior probabilities (.0.95) in each case (Figure 1), and
was robust to the exclusion of positions in the reverse transcriptase
gene at which shared drug resistance mutations were present
(positions 85, 103, 184, 190, 215).
We used a Bayesian MCMC approach to estimate the dates of
most recent common ancestors (MRCA) for the UK-Brazil, and
UK MSM clades. For the UK-Brazil clade the estimated time of
the MRCA was 1980 (1972 to 1987) under a ‘‘relaxed molecular
clock’’ model and 1977 (1969 to 1985) under a ‘‘strict clock’’
model. These estimates approximately correspond to those
previously calculated for the MRCA of the South American
epidemic [12]. For the UK MSM clade we estimated an origin in
1992 (1988–1997) using a relaxed clock model, and 1990 (1985 to
1994) using a strict clock model. Alternative demographic models
gave comparable results (data not shown).
Discussion
The data presented here provide clear evidence of an
epidemiological link between subtype C epidemics in East Africa,
South America, and the UK. While previous studies of the subtype
C epidemic in South America have indicated a link to East Africa
[12], the nature of this link has remained mysterious, particularly
since social, cultural, and economic relationships between the two
regions are limited. The UK fits well as the missing piece in this
puzzle. Firstly, it is home to large Brazilian and East African
immigrant populations (i.e. .100,000 individuals), both of which
are concentrated in London [32,33]. Furthermore, these popula-
tions are skewed toward adults between the ages of 20 and 30, a
demographic likely to be involved in high-risk behaviors associated
with transmission of HIV-1 [34]. It should also be noted that both
Brazil and East Africa are reported destinations for UK ‘sex
tourism’ (defined as travel specifically for the purpose of engaging
in sexual activity) [35]. All of these factors can be considered likely
to have played a role in the emergence of linked subtype C
epidemics in the three distinct geographic regions.
The African origin of HIV-1 is now well established [36].
Assuming that the reference sequences used in this analysis
provide an adequate representation of global subtype C diversity,
our data support a scenario under which East African subtype C
strains were introduced first to the UK, and subsequently to Brazil.
Although alternative scenarios cannot be conclusively ruled out by
our analysis, transfer from East Africa to Brazil via the UK is
consistent with cultural and demographic data (see above) as well
with the phylogenetic and temporal structuring of infections
(Figure 1). The intermingling of sequences from the UK and Brazil
in phylogenies also raises the possibility that multiple transfers of
subtype C viruses between the UK and Brazil (in both directions)
may have occurred in recent times.
The identification of a well-supported and relatively large
cluster of subtype C infections in Caucasian males, the majority of
whom were born in the UK and reported their exposure risk as sex
Figure 1. Bayesian tree of HIV-1 subtype C pol sequences. Evolutionary relationships between 54 United Kingdom, 87 Brazilian and 120 non-
Brazilian subtype C pol sequences, estimated using Bayesian phylogenetic analysis, are shown. Colors on terminal branches and terminal nodes
indicate the geographic location of sampling, as shown in the key (bottom right). Asterisks indicate nodes with posterior probability values of 0.95 or
higher. Brackets indicate clades comprised of sequences sampled from a specific geographic region, and with posterior probability values above 0.95.
The mean dates of the most recent common ancestors to the ‘UK and Brazil’ and ‘UK-MSM’ clades are indicated alongside the corresponding internal
nodes (white circles). Note that the majority (n=8,266, .99%) of the UK subtype C sequences examined in this report grouped within the ‘Africa and
Asia’ clade in preliminary analysis and are not shown here.
doi:10.1371/journal.pone.0009311.g001
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within the UK. This observation reinforces previous reports that
the HIV-1 epidemic in UK MSM, which is historically associated
with subtype B viruses, is diversifying [19]. The estimated time of
the MRCA for the cluster of subtype C infections identified in UK
MSM (Figure 1) approximately corresponds to that estimated for a
cluster of subtype A infections identified previously in the same
exposure risk population (1989–1994) [19]. Together, these data
indicate that diverse non-subtype B strains have been circulating
amongst MSM in the UK for nearly two decades, sufficient time
for infections to have spread within this population and,
potentially, to epidemiologically linked populations throughout
Europe [37]. The increasing diversity of the HIV-1 epidemic
amongst UK MSM may have implications for future diagnosis,
treatment and prevention in this exposure risk group [2].
The data presented here reveal a novel perspective on the origin
and evolutionary history of the subtype C epidemic in South
America, and emphasize the role of diffuse international networks
in the global dissemination of HIV-1. In addition, this analysis
further demonstrates the utility of globally sampled viral sequence
data in unraveling the complex routes by which sexually
transmitted infections spread across international borders.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0009311.s001 (0.06 MB
DOC)
Figure S1 Maximum likelihood phylogenetic tree based on 999
nucleotides of pol gene sequence (nucleotides 2,253–3,251 (HXB2
coordinates)) from 1,427 HIV-1 subtype C isolates. Sequences
were isolated in the following countries; Argentina (n=8); Burundi
(n=92); Brazil (n=122); Botswana (n=144); Ethiopia (n=101);
India (n=74); Kenya (n=3); Tanzania (n=65); Uganda (n=11);
South Africa (n=667); UK (unpublished sequences n=138) (total
n=140). Monophyletic clusters are marked as follows; grey
(African cluster); yellow (Indian cluster); brown (Ethiopia/Burundi
cluster); green (Burundi/UK cluster); blue (UK/Brazilian cluster).
Tip branches representing UK sequences are colored white.
Marked clusters showed aLRT support .0.7.
Found at: doi:10.1371/journal.pone.0009311.s002 (0.12 MB
PDF)
Figure S2 Detailed maximum likelihood phylogenetic tree
showing tip and node aLRT values, and constructed using 999
nucleotides of pol gene sequence (nucleotides 2,253–3,251 (HXB2
coordinates)) from 1,427 HIV-1 subtype C isolates. Sequences
were isolated in the following countries; Argentina (n=8); Burundi
(n=92); Brazil (n=122); Botswana (n=144); Ethiopia (n=101);
India (n=74); Kenya (n=3); Tanzania (n=65); Uganda (n=11);
South Africa (n=667); UK (unpublished sequences n=138) (total
n=140). Monophyletic clusters are marked as follows; grey
(African cluster); yellow (Indian cluster); brown (Ethiopia/Burundi
cluster); green (Burundi/UK cluster); blue (UK/Brazilian cluster).
Tip branches representing UK sequences are colored white.
Marked clusters showed aLRT support .0.7.
Found at: doi:10.1371/journal.pone.0009311.s003 (4.88 MB
PDF)
File S1
Found at: doi:10.1371/journal.pone.0009311.s004 (0.09 MB
DOC)
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